Want to see MRM full AI Analyst Report?
MRM Stock Chart & Stats
$1.93
-$0.05(-4.46%)
At close: 4:00 PM EST
$1.93
-$0.05(-4.46%)
Day’s Range― - ―
52-Week Range$0.90 - $4.45
Previous CloseN/A
Volume24.15K
Average Volume (3M)4.82M
Market Cap
$7.88M
Enterprise Value$3.27B
Total Cash (Recent Filing)$38.76M
Total Debt (Recent Filing)$3.91B
Price to Earnings (P/E)―
Beta1.12
Next Earnings
Nov 09, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)62.59
Shares Outstanding7,901,950
10 Day Avg. Volume3,803,708
30 Day Avg. Volume4,821,025
Financial Highlights & Ratios
PEG Ratio0.24
Price to Book (P/B)0.89
Price to Sales (P/S)0.10
P/FCF Ratio-0.44
Enterprise Value/Market Cap414.51
Enterprise Value/Revenue0.41
Enterprise Value/Gross Profit1.62
Enterprise Value/Ebitda12.65
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Recurring & Diversified Revenue ModelMEDIROM’s mix of tiered telemedicine subscriptions, product sales and service agreements builds recurring and diversified revenues. That business model provides predictable cash inflows, cross-sell opportunities and resilience versus single-product firms, supporting steadier medium-term growth.
Strategic World ID Infrastructure WinThe Master Service Agreement to roll out World ID Orbs at ~3,000 sites converts MEDIROM’s physical salon footprint into national authentication infrastructure. This creates a durable operational-fee revenue stream, strengthens network effects and positions the company as a strategic HealthTech/identity partner in Japan.
Expanded Distribution Via TD SYNNEX PartnershipTeaming with TD SYNNEX gives MEDIROM access to a large reseller network, accelerating device and system rollout nationwide. Improved distribution lowers go-to-market cost, speeds adoption of health-monitoring products and supports sustainable device and service revenue growth over the medium term.
Bears Say
High Leverage / Low Equity RatioA low equity ratio and material debt-to-equity indicate heavy reliance on debt financing. Elevated leverage raises interest expense and refinancing sensitivity, limiting strategic flexibility and increasing solvency risk if operational performance weakens over the next several quarters.
Deteriorating Free Cash FlowA sharp drop in free cash flow and negative operating-cash-to-net-income metrics reflect liquidity stress. Persistent negative cash generation forces dependence on external financing, constraining the company’s ability to self-fund growth or absorb shocks in the medium term.
Profitability ShortfallsDespite revenue gains and improving gross margins, MEDIROM reported negative EBIT and narrow profitability. Continued operating losses mean top-line growth is not yet translating into durable earnings or free cash flow, requiring further margin expansion or scale to reach self-sustaining profitability.
MEDIROM Healthcare Technologies News
MRM FAQ
What was MEDIROM Healthcare Technologies’s price range in the past 12 months?
MEDIROM Healthcare Technologies lowest stock price was $0.90 and its highest was $4.45 in the past 12 months.
What is MEDIROM Healthcare Technologies’s market cap?
MEDIROM Healthcare Technologies’s market cap is $7.88M.
When is MEDIROM Healthcare Technologies’s upcoming earnings report date?
MEDIROM Healthcare Technologies’s upcoming earnings report date is Nov 09, 2026 which is in 132 days.
How were MEDIROM Healthcare Technologies’s earnings last quarter?
Currently, no data Available
Is MEDIROM Healthcare Technologies overvalued?
According to Wall Street analysts MEDIROM Healthcare Technologies’s price is currently Overvalued.
Does MEDIROM Healthcare Technologies pay dividends?
MEDIROM Healthcare Technologies does not currently pay dividends.
What is MEDIROM Healthcare Technologies’s EPS estimate?
MEDIROM Healthcare Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MEDIROM Healthcare Technologies have?
MEDIROM Healthcare Technologies has 7,901,950 shares outstanding.
What happened to MEDIROM Healthcare Technologies’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of MEDIROM Healthcare Technologies?
Currently, no hedge funds are holding shares in MRM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
MEDIROM Healthcare Technologies
MEDIROM Healthcare Technologies Inc. (MRM) is a Japanese company that offers comprehensive healthcare solutions, operating through two primary divisions: Relaxation Salon and Digital Preventative Healthcare. The Relaxation Salon segment oversees a network of both company-owned and franchised wellness centers, which include brands like Re.Ra.Ku and Ruam Ruam. These salons deliver various therapeutic services, such as finger-pressure bodywork, stretch therapy, posture and joint alignment, and aspects of physical therapy. They also provide specialized treatments for fatigue relief, athletic support, weight management, and reflexology. By the close of 2021, this division managed 312 such relaxation salons. The Digital Preventative Healthcare segment is dedicated to proactive health management through technology. It participates in government-mandated Specific Health Guidance programs, primarily leveraging its proprietary on-demand health monitoring smartphone application, Lav. This segment also features MOTHER Tracker for fitness tracking and provides general preventative healthcare services using its digital platforms and devices. Furthermore, MEDIROM operates the Re.Ra.Ku College in Tokyo's Odaiba area. This college offers continuous professional development for franchise owners, corporate staff, and salon employees, covering essential skills in customer service, salon management, and advanced relaxation techniques. Headquartered in Tokyo, Japan, the company was established in 2000. It adopted its current name, MEDIROM Healthcare Technologies Inc., in March 2020, having previously been known as MEDIROM Inc.
Technical Analysis
Ownership Overview
―
Insiders
―
Mutual Funds
0.74% Other Institutional Investors
99.26% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---